Management of Suspected Fecal Calprotectin False Positive Results
When faced with a suspected false positive fecal calprotectin result, repeat testing after approximately 18 days is recommended as this can show reduction in calprotectin levels in up to 53% of patients with initially elevated results. 1
Common Causes of False Positive Results
- Non-steroidal anti-inflammatory drugs (NSAIDs) use within the past 6 weeks can cause false elevations in fecal calprotectin and should be discontinued before testing 2, 3
- Presence of hemorrhoids or other sources of gastrointestinal bleeding can elevate calprotectin levels without indicating inflammatory bowel disease 2
- Liver cirrhosis has been associated with false positive calprotectin results 3
- Infectious gastroenteritis will cause elevated calprotectin and cannot be distinguished from IBD by calprotectin alone 4
- Colorectal cancer and advanced adenomas can also cause elevated calprotectin levels 2
Diagnostic Approach for Suspected False Positives
Initial Assessment
- Review medication history, particularly focusing on recent NSAID use 3
- Evaluate for other potential causes of inflammation including infectious gastroenteritis through stool cultures 4
- Consider the clinical context - calprotectin is not recommended for patients with rectal bleeding, abdominal pain, change in bowel habit, weight loss, or iron-deficiency anemia where cancer pathway referral should be prioritized 1
Follow-up Testing
- For mildly elevated results (100-250 μg/g), repeat testing after approximately 18 days is recommended 1, 4
- For patients with elevated calprotectin but no symptoms, repeat measurement in 3-6 months is reasonable before proceeding to endoscopy 5
- If calprotectin remains elevated on repeat evaluation, endoscopic assessment is warranted 5
Interpretation of Results Based on Clinical Context
For Patients with Mild Symptoms (100-250 μg/g)
- The negative predictive value of a fecal calprotectin between 100-200 μg/g in excluding significant organic GI disease is high (97.5% for significant luminal pathology) 6
- In adult patients under 50 years with new lower GI symptoms and mildly elevated calprotectin (100-200 μg/g), only 2.5% were eventually diagnosed with IBD after long-term follow-up 6
For Patients with Moderate to Severe Symptoms
- Endoscopic assessment (flexible sigmoidoscopy or colonoscopy) is recommended rather than relying solely on calprotectin results 1
- Stool culture and/or flexible sigmoidoscopy or colonoscopy are the appropriate diagnostic investigations in acute presentations 4
Practical Considerations for Calprotectin Testing
- The first stool passed in the morning should be routinely used for sampling 1
- Samples should be stored for no more than 3 days at room temperature before analysis 1
- Variability exists between different calprotectin assays, and results should be interpreted according to local laboratory reference ranges 4
- Home fecal calprotectin testing can be a valid alternative when access to laboratory testing is limited 1
Clinical Algorithm for Managing Suspected False Positive Results
Verify pre-test conditions:
Evaluate clinical context:
- If patient has alarm symptoms (rectal bleeding, weight loss, anemia), proceed directly to endoscopic evaluation regardless of calprotectin level 1
- For patients with mild symptoms and calprotectin 100-250 μg/g, consider repeat testing 1, 4
- For patients with moderate-severe symptoms, proceed to endoscopic evaluation 1
Repeat calprotectin testing:
Endoscopic evaluation:
By following this structured approach, clinicians can appropriately manage suspected false positive calprotectin results while minimizing unnecessary investigations and ensuring that significant pathology is not missed.